Tetrahedron Letters
Synthesis of novel chiral biquinolyl diphosphine ligand and its
applications in palladium-catalyzed asymmetric allylic substitution
reactions
a
a
a
b
a,
⇑
Rui Zhang , Bin Xie , Guo-Shu Chen , Liqin Qiu , Yi-Xin Chen
a
School of Chemistry and Chemical Engineering, Guangzhou University, 230 Wai Huan Xi Road, GuangZhou Higher Education Mega Center, Guangzhou 510006, China
School of Chemistry and Chemical Engineering, Sun Yat-Sen University, 135, Xin Gang Xi Road, Guangzhou 510275, China
b
a r t i c l e i n f o
a b s t r a c t
0
0
Article history:
A novel chiral diphosphine ligand, 6,6 -bis(diphenylphosphino)-5,5 -biquinoline (BIQAP) was synthesized
via two step reactions using optical pure BIQOL as starting material and the molecular structure of
(
Received 21 October 2015
Revised 30 December 2015
Accepted 5 January 2016
Available online 6 January 2016
R)-BIQAP was determined by single-crystal X-ray diffraction. The ligand was used for Pd-catalyzed
asymmetric allylic substitution reactions. High enantioselectiveties were obtained in the corresponding
C–C and C–N bond formation of 1,3-diphenyl-2-propenyl acetate, with dimethyl malonate (up to 94% ee)
and with potassium phthalimide (up to 96% ee).
Keywords:
Ó 2016 Elsevier Ltd. All rights reserved.
Diphosphine ligand
Pd-catalyzed
Allylic alkylation
BIQAP
Introduction
Pd-catalyzed asymmetric allylic substitution reactions (see
Scheme 1 and Scheme 2).
Chiral phosphine ligands are a very successful type of ligands
used in asymmetric catalysis.1 Among them, BINAP is no doubt
one of the most effective chiral diphosphine ligands. So far
Results and discussion
2
diphosphine–metal complexes have been found to be versatile in
The chiral BIQAP ligand was obtained through a straightforward
two-step synthetic route using optical pure BIQOL as the starting
material. At first, ditriflate of (R)-BIQOL was prepared using
3
many catalytic reactions such as asymmetric hydrogenation, ary-
4
5
lation, allylic alkylation, etc. Moreover, a large number of exam-
ples of industrialization have been reported.6
(R)-BIQOL and triflate in an ice bath. Then, a coupling reaction
Pd-catalyzed asymmetric allylic alkylation7 is
a powerful
between ditriflate L2 and diphenylphosphine was carried out with
approach to stereoselective C–C, C–N, and C–O bonds formation
in synthetic organic chemistry. As such its asymmetric version
using a chiral ligand has also been extensively studied in the past
a Ni-based catalyst and 1,4-diaza[2.2.2]bicyclooctane (DABCO) in
DMF at 120 °C for 72 h. Numerous nickel catalysts such as NiCl
NiCl /dppp, NiCl ꢀ(Ph P) were screened and it is found
ꢀdppe, NiCl
that only NiCl
2
,
2
2
2
3
2
8
decades. In order to achieve high enantioselectivity from racemic
2
ꢀdppe catalyzed (R)-BIQAP formation.
or achiral allylic substrates, the development of a novel chiral
X-ray single crystal diffraction analysis of (R)-BIQAP revealed
the presence of diphenylphosphino moiety in the ligand via C–P
binding in an orthorhombic crystal system and the space-group
ligand is an essential and challenging task.9 In 2000, Chan and
2
co-workers once reported a C -symmetric, heterocyclic chiral
0
0
10
ligand, 6,6 -dihydroxy-5,5 -biquinoline (BIQOL)
which has a
1 1 1
is P2 2 2 (19). The interplanar angle of the least-squares of the
biquinoline is 90° (Fig. 1).
With chiral ligand BIQAP in hand, we first examined its catalytic
activity under the Pd-catalyzed asymmetric allylic alkylation reac-
tion. rac-1,3-Dipenylpropen-1-yl acetate reacted with dimethyl
skeleton similar to that of BINOL. Since then the BIQOL ligand
has been applied to many kinds of reactions and showed good
1
0,11
enantioselectivity.
Herein we report its further development
0
for the preparation of novel BIQAP ligand 6,6 -bis(diphenylphos-
phino)-5,5 -biquinoline and the corresponding application in
0
malonate (3.0 equiv) in the presence of (S)-BIQAP (5.0 mol %), [Pd
3
(
3
g
-C
3
H
5
)Cl]
2
(2.5 mol %), N,O-bis(trimethylsilyl)acetamide (BSA,
(0.1 equiv). The latter was acted as BSA
equiv) and Zn(OAc)
2
⇑
activator.
040-4039/Ó 2016 Elsevier Ltd. All rights reserved.
0